These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
428 related articles for article (PubMed ID: 9316038)
1. Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms. Kondziolka D; Flickinger JC; Bissonette DJ; Bozik M; Lunsford LD Neurosurgery; 1997 Oct; 41(4):776-83; discussion 783-5. PubMed ID: 9316038 [TBL] [Abstract][Full Text] [Related]
2. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era. Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327 [TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas. Gannett D; Stea B; Lulu B; Adair T; Verdi C; Hamilton A Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):461-8. PubMed ID: 7673034 [TBL] [Abstract][Full Text] [Related]
6. Stereotactic radiosurgery for recurrent malignant gliomas. Hall WA; Djalilian HR; Sperduto PW; Cho KH; Gerbi BJ; Gibbons JP; Rohr M; Clark HB J Clin Oncol; 1995 Jul; 13(7):1642-8. PubMed ID: 7602353 [TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for deep situated malignant gliomas treated with linac radiosurgery. Wang YY; Yang GK; Li SY; Baol XF; Wu CY Chin Med Sci J; 2004 Jun; 19(2):105-10. PubMed ID: 15250245 [TBL] [Abstract][Full Text] [Related]
8. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. Shrieve DC; Alexander E; Black PM; Wen PY; Fine HA; Kooy HM; Loeffler JS J Neurosurg; 1999 Jan; 90(1):72-7. PubMed ID: 10413158 [TBL] [Abstract][Full Text] [Related]
17. Radiosurgery in the management of pediatric brain tumors. Hodgson DC; Goumnerova LC; Loeffler JS; Dutton S; Black PM; Alexander E; Xu R; Kooy H; Silver B; Tarbell NJ Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):929-35. PubMed ID: 11429220 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of magnetic resonance imaging-guided stereotactic biopsy in the evaluation of recurrent malignant astrocytoma compared with a lesion due to radiation effect. McGirt MJ; Bulsara KR; Cummings TJ; New KC; Little KM; Friedman HS; Friedman AH J Neurosurg; 2003 Jan; 98(1):14-20. PubMed ID: 12546347 [TBL] [Abstract][Full Text] [Related]
19. Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery. Rostomily RC; Spence AM; Duong D; McCormick K; Bland M; Berger MS Neurosurgery; 1994 Sep; 35(3):378-88; discussion 388. PubMed ID: 7800129 [TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy. Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]